Pharmaceutical Market Access and Drug Safety Act of 2007

A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.

1/10/2007--Introduced.
Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by:
(1) a registered importer; or
(2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from:
(1) discriminating against registered exporters or importers;
(2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country;
(3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or
(4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.


... morehide bill summary

Sponsor

• Sen. Byron Dorgan [D, ND]
• and 36 Co-Sponsors
  • Sen. Jeff Bingaman [D, NM]
  • Sen. Barbara Boxer [D, CA]
  • Sen. Sherrod Brown [D, OH]
  • Sen. Robert Casey [D, PA]
  • Sen. Hillary Clinton [D, NY]
  • Sen. Susan Collins [R, ME]
  • Sen. Kent Conrad [D, ND]
  • Sen. Richard Durbin [D, IL]
  • Sen. Russell Feingold [D, WI]
  • Sen. Dianne Feinstein [D, CA]
  • Sen. Charles Grassley [R, IA]
  • Sen. Daniel Inouye [D, HI]
  • Sen. Tim Johnson [D, SD]
  • Sen. Edward Kennedy [D, MA]
  • Sen. John Kerry [D, MA]
  • Sen. Amy Klobuchar [D, MN]
  • Sen. Herbert Kohl [D, WI]
  • Sen. Patrick Leahy [D, VT]
  • Sen. Carl Levin [D, MI]
  • Sen. Blanche Lincoln [D, AR]
  • Sen. John McCain [R, AZ]
  • Sen. Claire McCaskill [D, MO]
  • Sen. Bill Nelson [D, FL]
  • Barack Obama
  • Sen. Mark Pryor [D, AR]
  • Sen. Ken Salazar [D, CO]
  • Sen. Bernard Sanders [I, VT]
  • Sen. Charles Schumer [D, NY]
  • Sen. Olympia Snowe [R, ME]
  • Sen. Arlen Specter [D, PA]
  • Sen. Debbie Ann Stabenow [D, MI]
  • Sen. Jon Tester [D, MT]
  • Sen. John Thune [R, SD]
  • Sen. Jim Webb [D, VA]
  • Sen. Sheldon Whitehouse [D, RI]
  • Sen. Ron Wyden [D, OR]
  close

Committees

• Senate Health, Education, Labor, and Pensions
• 1 more
  • Senate Health, Education, Labor, and Pensions
  close

Amendments

This bill has no amendments.

Amendments to S.242

Number	Status	Purpose

Bill Status

Make a Bill Status Widget

	OpenCongress widgets allow you to display information about bills and issue areas on your own website or blog. First, select which bill or issue you want to track, then customize the appearance of the panel, and finally paste a simple chunk of HTML into your site. Now your community will have an easy, up-to-date way to track the status of important bills and issues in Congress.

Introduced		Voted on by Senate		Voted on by House		Considered By President		Bill Becomes Law
January 10, 2007

Show All Actions (5 actions)Hide Actions

All Bill Actions

• Mar 07, 2007: Committee on Commerce, Science, and Transportation Subcommittee on Interstate Commerce, Trade, and Tourism. Hearings held.
• Jan 10, 2007: Introductory remarks on measure. (CR S384-385)
• Introduced on Jan 10, 2007.
• Jan 10, 2007: Sponsor introductory remarks on measure. (CR S384-385)
• Jan 10, 2007: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

---

Related Bills:

• H.R.380

Related Issue Areas:

• Medicine
• Accreditation (Medical care)
• Actions and defenses
• Administrative fees
• 95 more
• Administrative procedure
• Administrative remedies
• Australia
• Budgets
• Business
• Business records
• Canada
• Checks
• Civil liberties
• Congress
• Congressional reporting requirements
• Consumer education
• Consumers
• Contracts
• Credit cards
• Criminal justice
• Customs administration
• Damages
• Defective products
• Department of Health and Human Services
• Directories
• Drug advertising
• Drug approvals
• Drug industry
• Drugs
• East Asia
• Education
• Electronic commerce
• Electronic data interchange
• Electronic funds transfers
• Electronic government information
• Europe
• European Union
• Evidence (Law)
• Executive departments
• Export controls
• Exports
• Federal Trade Commission
• Federal preemption
• Federal-state relations
• Finance
• Fines (Penalties)
• Food and Drug Administration (FDA)
• Forfeiture
• Fraud
• Government information
• Government paperwork
• Government publicity
• Governmental investigations
• Higher education
• Identification devices
• Import restrictions
• Imports
• Independent regulatory commissions
• Injunctions
• Intellectual property
• Interactive media
• Internet
• Japan
• Labeling
• Law
• Liability (Law)
• Licenses
• Medical associations
• Medical care
• Medical education
• Medical records
• Medical tests
• New Zealand
• Oceania
• Packaging
• Parties to actions
• Patent infringement
• Patents
• Pharmaceutical research
• Pharmacies
• Pharmacists
• Physical examinations
• Prescription pricing
• Price discrimination
• Product counterfeiting
• Restrictive trade practices
• Right of privacy
• Science policy
• State and local government
• State laws
• Surety and fidelity
• Switzerland
• Technology
• Telecommunication
• Telephone
• Trade
• User charges
• Web sites
• Wholesale trade

Data from the Congressional Research Service

Show More User Statistics... Hide User Statistics

In the News

June 20, 2007 NCPD Files Amicus Brief to Eliminate FDA Regulatory Scheme That ...

Congress has listened; new legislation is under consideration in both houses of Congress (S. 242 and HR 380) that would do away with the arbitrary exemption ...

Was this article useful? Yes or No

Source: Earthtimes.org

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

March 14, 2007 Cutting US drug prices through imports will hit R&D

S 242, which is sponsored by Senators Byron Dorgan (Democrat) and Olympia Snowe (Republican), "balances the challenge of designing a prescription drug ...

Was this article useful? Yes or No

Source: Pharma Times (subscription), UK

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

February 21, 2007 AARP CEO Sets Association Priorities That Promote Health and Long ...

... provide Medicare the authority to bargain for lower drug prices; -- Providing for the safe and legal importation of prescription drugs (S. 242/HR 380); ...

Was this article useful? Yes or No

Source: PR Newswire (press release), NY

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

2 more articles...
See most useful news articles

Information made available by:

Blog Coverage

January 06, 2009 Revierflaneur» Blogarchiv » Dienstag, 6. Januar 2009: Sehr gut?

Und auf S. 242: “Wenn ein Gott diese Welt gemacht hat, so möchte ich nicht der Gott seyn: ihr Jammer würde mir das Herz zerreissen.” Und ist es nicht tatsächlich die Theodizeefrage, an der sich die Geister scheiden? ...

Was this article useful? Yes or No

Source: Revierflaneur

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

December 29, 2008 Ghassan Kanafani und die Literatur des Widerstands

11. Ghassan Kanafani, The Complete Works: The novels, volume 1, Arab Research Association, Beirut, 4. Edition, S. 242. Quellen: Ghassan Kanafani: Men in the Sun, Returning to Haifa; PFLP.ps. Teile mit der Welt: ...

Was this article useful? Yes or No

Source: International Solidarity Movement Germany

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

December 10, 2008 Drug Channels: Drug Importation: A New Beginning?

He was no longer in the Senate by the time the 2007 version (S.242 Pharmaceutical Market Access and Drug Safety Act of 2007) came along, so he could not join then-Senator Obama in supporting this bill. The conventional wisdom suggests ...

Was this article useful? Yes or No

Source: Drug Channels

Did you find this article useful? Your opinion counts - together, we're finding the very best news and blog coverage about Congress available on the web.

43 more posts...
See most useful blog posts

Information made available by: